Atorvastatin generally shows greater efficacy in lowering LDL cholesterol compared to Simvastatin, potentially offering better cardiovascular protection.

Safety profiles of Atorvastatin and Simvastatin are similar, but Atorvastatin can be more potent at lower doses, reducing potential side effects.

Atorvastatin is more effective at higher intensity lipid lowering in patients with significant cardiovascular risk, achieving greater reductions in LDL-C levels.

Simvastatin is cost-effective but Atorvastatin may provide a greater reduction in cardiovascular events due to its stronger lipid-lowering ability.